Gut and Intraplaque Microbiota in Atherosclerosis: Mechanistic Insights and Emerging Therapeutic Targets
Open Access
- 13 October 2026
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 14 (10) , 2333
Abstract
Atherosclerosis remains a major cause of cardiovascular morbidity and mortality. Growing evidence suggests that microbiota–host interactions contribute to atherosclerosis through systemic and local mechanisms. This review summarizes current evidence on gut microbiota, microbial metabolites, and plaque-associated microbial signals, and discusses their potential therapeutic implications. Gut dysbiosis may contribute to atherosclerosis through multiple metabolite-dependent, immune, vascular, and metabolic pathways. Recent multi-omics and experimental studies further indicate that microbiota influence vascular biology beyond compositional changes alone. In parallel, plaque-associated microbial signals, potentially originating from the oral cavity or gut, may contribute to local inflammation, oxidative stress, necrotic core expansion, and plaque vulnerability. We further discuss a putative gut–oral–intraplaque axis, a potential local microbial metabolite microenvironment within plaques, and possible cross-kingdom interactions between gut fungi and bacteria. Together, these findings support an integrated framework in which microbiota may shape atherosclerosis through interconnected systemic and local pathways, with potential implications for biomarker development and microbiota-targeted therapies.Keywords
Funding Information
- Natural Science Foundation of Beijing Municipality (L248071)
- Beijing Physician Scientist Training Project (BJPSTP-2026-18)
- National Key Research and Development Program of China (2023YFC2415100)
- Capital’s Funds for Health Improvement and Research (2026-2-4013)
- National High Level Hospital Clinical Research Funding (2025-PUMCH-A-179)
- National Natural Science Foundation of China (82470516)
- National Natural Science Foundation of China (825B2013)
- National Natural Science Foundation of China (62503501)
This publication has 135 references indexed in Scilit:
- Comparative Effects of Probiotics, Prebiotics, and Synbiotics on Clinical Outcomes in Coronary Artery Disease: A Systematic Review and Meta-AnalysisProbiotics and Antimicrobial Proteins, 2026
- Distinct microbial and metabolic shifts characterize acute coronary syndrome and recoveryiMeta, 2025
- Microbiota‐derived 3‐Methyl‐L‐histidine mediates the proatherogenic effect of high chicken protein dietMedcomm, 2025
- The Metabolite Indole‐3‐Acetic Acid of Bacteroides Ovatus Improves Atherosclerosis by Restoring the Polarisation Balance of M1/M2 Macrophages and Inhibiting InflammationAdvanced Science, 2025
- The Type III Secretion System (T3SS) of Escherichia Coli Promotes Atherosclerosis in Type 2 Diabetes MellitusAdvanced Science, 2025
- Manno‐oligosaccharides from Cassia Seed Gum Attenuate Atherosclerosis through Inflammation Modulation and Intestinal Barrier Integrity Improvement in ApoE−/− MiceMolecular Nutrition & Food Research, 2023
- Microbiome composition comparison in oral and atherosclerotic plaque from patients with and without periodontitisOdontology, 2020
- The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular diseaseEuropean Journal of Immunology, 2017
- The Effects of Synbiotic Supplementation on Carotid Intima-Media Thickness, Biomarkers of Inflammation, and Oxidative Stress in People with Overweight, Diabetes, and Coronary Heart Disease: a Randomized, Double-Blind, Placebo-Controlled TrialProbiotics and Antimicrobial Proteins, 2017
- Demonstration of Viable Chlamydia pneumoniae in Atherosclerotic Plaques of Carotid Arteries by Reverse Transcriptase Polymerase Chain ReactionAnnals of Vascular Surgery, 1999